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The upper alimentary tract is the portal of entry for enteric viruses. After ingestion, 
viruses may infect cells in the throat, the stomach, or the small intestine. Those viruses 
that  multiply  primarily  in  the  small  intestine,  such  as  the  human  rotaviruses, 
polioviruses, Coxsackie, ECHO  virus, hepatitis A, and Norwalk agent  (1,  2),  come 
into  direct  contact  with  intestinal  fluids  consisting  mainly  of acids,  proteolytic 
enzymes, and bile. Enteroviruses, such as Coxsackie, ECHO virus, and polioviruses, 
are known to be resistant to bile salts and acid (2,  3).  Viral resistance to intestinal 
contents is clearly important if infection is to succeed. 
The mammalian reoviruses serotypes 1, 2, and 3 have been isolated primarily from 
the  feces  and  are  thus  enteric  viruses  (4,  5).  They  are  known  to  be  resistant  to 
inactivation by bile salts as well as acid ([2]; and D. Drayna. Personal communica- 
tion.). A number of investigators have examined the response of reoviruses to digestion 
by proteolytic enzymes in vitro. McClain et al. (6) and Spendlove et al. (7, 8) initially 
reported that the infectivity of different mammalian reoviruses could be enhanced or 
depressed  after treatment  with  chymotrypsin. Subsequently Joklik  (9)  found that 
treatment of reovirus with chymotrypsin degraded the outer capsid polypeptides via 
a  series  of steps.  The  precise  pattern  of degradation  was  dependent  upon  virus 
concentration, concentration of chymotrypsin, and ionic strength of the suspending 
medium. Shatkin and La Fiandra (10) isolated partially uncoated infectious subviral 
particles after digestion of purified reovirus with chymotrypsin and noted that 0.14 M 
NaCI  present  in the reaction  mixture protected reovirus against  loss  of infectivity. 
Borsa et al. (11-13) have suggested that there are two discrete stages of uncoating: the 
first stage is proteolytically mediated and generates infectious subviral particles, and 
the  second  stage  is  mediated  by  an  endogenous  mechanism  that  is  triggered  by 
intracellular concentrations of K ÷ ions and results in more complete uncoating, loss 
of infectivity, and transcriptase activation. Although the precise biochemical steps are 
not completely understood, Joklik  (9)  has  found that  cleavage of/.tic  (previously 
termed #2)  is associated with loss of infectivity and activation of transcription. 
Reovirions contain 10 segments of double-stranded RNA (dsRNA).I These segments 
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are named according to size classes: three large segments (LI, L2, L3), three medium 
segments (M1, M2, M3), and four small segments (S1, $2, $3, $4). In the virion, the 
dsRNA  is surrounded  by a  double capsid:  an  internal  core that  contains  the  viral 
transcriptase and an outer capsid (14). The outer capsid contains three polypeptides, 
#IC  (derived  by cleavage  from the  primary #1  polypeptide),  ol,  and  o3  that  are 
encoded  by dsRNA genome segments M2,  S1,  and  $4,  respectively (15-18).  Using 
hybrid recombinant clones consisting of genome segments derived  from serotype  1, 
strain  Lang,  or serotype  3,  strain  Dearing,  we have shown  previously that  the  ol 
polypeptide is the viral hemagglutinin (15). The ol polypeptide, in addition, serves as 
the type-specific neutralization antigen  (19), determines cell tropism (20), and binds 
to cellular microtubules (21). 
The  Dearing  strain  of serotype  3  reovirus  is  highly  virulent  after  intracerebral 
inoculation  (20).  This pattern of neurovirulence  after intracerebral  inoculation  has 
been shown to be primarily a property of the S1 gene product (the viral hemaggluti- 
nin) (20). When we inoculated this strain perorally into suckling mice, it was avirulent. 
Our study was undertaken to understand why the Dearing strain ofserotype 3 reovirus 
was  avirulent  after  peroral  inoculation.  We  also  were  interested  in  defining  how 
reovirus interacts with the mammalian host during passage through the gastrointes- 
tinal  tract.  We now report  that:  (a)  there are marked differences between  reovirus 
serotypes  1,  strain  Lang  and  3,  strain  Dearing  in  their  sensitivity  to  proteolytic 
enzymes and growth in intestinal tissue; (b) these differences are a property of the #IC 
outer capsid polypeptide, which is encoded in genome segment M2; and (c) sensitivity 
or resistance of the # 1C polypeptide to proteolysis correlates with the ability to initiate 
systemic infection after administration of virus by peroral intubation.  Thus the M2 
dsRNA genome segment is a  virulence gene. 
Materials and Methods 
Virus.  Reoviruses  serotype 1, strain Lang, and serotype 3, strain Dearing, have previously 
been described  (22). Recombinant clones used in these experiments were prepared by infecting 
L  cells with equal  multiplicity of temperature-sensitive (ts)  mutants of reovirus serotype 3, 
strain Dearing and clones derived from serotype 1, strain Lang (23, 24). The parental origins 
of each dsRNA segment, as well as the serotype 3 ts mutant used to generate each recombinant 
clone, are listed in Table I. All virus clones were double plaque purified and passaged on L cell 
monolayers twice. A third passage was grown in L cell spinner culture and purified according 
to published  methods  (22). The pure virus was collected  from CsC! gradient  and dialyzed 
against 0.15 M sodium chloride and 0.015 M sodium citrate, pH 7.4. The same purified viral 
stocks were used for in vitro and in vivo experiments. 
Cells and  Viral  Titrations.  Mouse L cells were maintained as previously described (22). All 
viral titrations were performed on L cell monolayers in Costar 6 well plates (3506; Costar Data 
Packaging, Cambridge, Mass.).  For plaque assays, we used previously described methods (25) 
adapted for the smaller surface area. Titrations were performed at 37°C (CO~ incubator 3331- 
2; National Appliance Co., Hollywood, Fla.). 
Assays for  Chyraot~ypsin.  A stock solution of 1 mg/ml chymotrypsin (CHT)  (C4129,  three 
times crystallized;  Sigma Chemical, Co., St. Louis, Mo.) was prepared. The specific activity of 
the CHT solution  was determine by spectrophotometric assay using benzoyI-L-tyrosine-ethyl 
ester (BTEE) as substrate (26). The activity of aliquots of CHT stored at -70°C was determined 
at the beginning and end of each experiment. No change in activity was observed. 
To measure CHT activity in intestinal tissue, the small intestine  of 1- to 2-d-old  mice was 
divided at the gastroduodenal junction and cecum and placed in  1 ml of distilled  water. The 
samples were sonicated until a  fine suspension was obtained.  Because  the BTEE specifically 
measures CHT activity, the intrinsic brush border enzymes on the surface of intestinal cells (27, DONALD H.  RUBIN AND BERNARD N.  FIELDS 
TABLE  I 
Genotype of Reovirus Clones 
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Serotype 3,  Parental origin of genome segments 
Serotype  strain Dearing 
ts mutant  Other capsid  Core  Nonstruc-  or recom-  used as parent  rural 
binant  for recombi- 
nant  M2  SI  $4  LI  L2  L3  M1  $2  M3  $3 
1  1  1  1  1  1  1  1  1  1  1 
3  3  3  3  3  3  3  3  3  3  3 
65  tsC (447)  1  1  1  3  3  3  3  1  3  1 
54  tsB (352)  1  1  3  3  1  1  1  3  3  3 
63  tsB (352)  1  3  3  3  1  1  1  1  1  1 
204  tsD (357)  1  3  1  3  1  i  1  1  1  1 
402  tsE (320)  3  3  1  3  3  3  3  3  3  3 
502  tsC (447)  3  3  3  1  3  3  3  3  3  3 
602  tsC (447)  3  3  1  l  3  3  3  3  3  3 
802  tsC (447)  3  1  3  1  3  3  3  3  3  3 
94  tsD (357)  3  3  1  1  3  3  1  1  3  I 
103  tsD (357)  3  1  1  1  3  3  3  3  3  3 
140  tsG (453)  3  1  1  I  1  1  1  1  3  3 
28) did not affect the assay. The Spectrophotometric assay noted above was used to determine 
enzymatic activity. The protein  content of intestinal  samples were determined  according to 
Lowry (29)  using bovine serum albumin as a  standard.  The CHT  activity was related to the 
protein  content  of small  intestine/100  g  body weight.  To determine  the amount  of enzyme 
protein/U of CHT activity, the total small intestinal CHT  activity was further correlated to 
the specific activity of purified CHT  by modifying the method of Hummel  (26).  A  standard 
curve of activity//xg of purified CHT was calculated and the intestinal activity was related to 
known concentrations of purified enzyme. 
For in vitro CHT digestions, 250 ~g of purified virus was diluted into  1.0 ml of buffer that 
contained 0.01  M  NaCI and 0.01  M  tris, pH 8.3. This virus solution was then further dialyzed 
against the same buffer, and  10/~1 (2.5 ~ag of virus) was then diluted into 1 ml of a solution that 
contained the appropriate cation solution buffered with 0.10 M  Tris, pH 8.3. 
Reaction mixtures with 10/~g CHT were incubated for 1 h at 37°C. Controls were incubated 
in a similar manner without CHT. Each point represents the mean of two samples. At the end 
of the incubation period, samples were rapidly cooled to 4°C and  1% aprotinin (A6012; Sigma 
Chemical Co.) was added to terminate the digestion (this concentration of aprotinin inhibited 
the enzyme activity). Serial dilutions were made in gelatin saline and 0.10-ml  aliquots were 
titered on L cell monolayers as indicated above. 
Assays of Growth of Virus in Intestinal Tissue 
INOCULATION OF VIRUS INTO STOMACH.  BALB/c pregnant  mice were  obtained  from  The 
Jackson Laboratory, Bar Harbor,  Maine and Laboratory Supply Co., Indianapolis,  Ind.  1- to 
2-d-old suckling mice were inoculated with suspensions of virus by passing a PE-10 polyethylene 
catheter  (Intramedic  polyethylene  tubing  inner  diameter  =  0.61  mm;  Clay Adams,  Div. of 
Becton,  Dickinson  &  Co.,  Parsipanny,  N. J.)  through  the mouth  and  into  the stomach.  To 
guarantee  delivery of virus  into  the  stomach,  0.06  ml  of blue  dye  (Durkee  Famous  Foods, 
Cleveland, Ohio) was added to virus suspended  in  10 ml gelatine saline. An inoculum of 0.05 
ml that contained ~ 1 ×  107 plaque-forming units (pfu) of the appropriate  virus was delivered 
with a  tuberculin syringe. 
VIRAL TITERS IN  INTESTINAL TISSUES AFTER PERORAL INOCULATION.  Mice were killed on days 
1, 2, and 3. Intestines were harvested from gastroduodenal junction to distal colon and washed 
three times in cold pbosphate-buffered saline. The small intestine was then separated from the 
colon and placed in 0.50 ml gelatin saline at 4°C. Tissue suspensions were prepared for titration 856  ROLE OF THE  REOVIRUS M2 GENOME SEGMENT  IN VIRULENCE 
by three sequential  freeze-thaw cycles followed by sonic treatment  for 20 sec  to disrupt  the 
remaining intact cells and viral aggregates. Virus was titered as above. 
TITERS OF VIRUS AFTER INCUBATION IN VITRO WITH GASTRIC FLUIDS OR  INTESTINAL TISSUE.  2-d- 
old mice were killed  and stomach and  intestine removed. The small  intestine was separated 
from the stomach at  the gastroduodenal junction and from the large intestine at the cecum. 
The stomach contents from two mice were pooled (~0.1  ml), diluted with an equal volume of 
solution that  contained 0.03  M  KCI and 0.01  M  NaCI, and sonicated.  The small  intestines 
from two mice were pooled and sonicated until homogenized. Reovirus serotypes 1 and 3 (2.5 
#g in  10 #1) were added to the gastric and small intestinal suspensions.  An initial aliquot was 
taken for titration and samples were incubated at 37°C for 2 h. Aliquots of each sample were 
removed for titration at  1 and 2 h. 
Mouse Survival.  Multiple litters of newborn mice were inoculated by peroral intubation with 
each parental serotype and selected recombinant clones. Survival was determined by recording 
the number of animals alive up to 3 wk after inoculation. Statistical analysis using contingency 
chi-square  was  used  to compare the  recombinant  clones  that  contained  the  serotype  3  S1 
dsRNA segment with serotype 3, strain Dearing. 
Results 
Digestion  by CHT Affects Reovirus  Serotypes  1 and 3  Differently.  The intestinal  fluids 
contain several proteases including the acid proteases; i.e., pepsins (30) and the serine 
proteases trypsin and CHT  (31). CHT is a major enzyme found in hi.gh concentration 
in the upper small intestine  (31), and it is known to be capable of digesting the outer 
shell  of mammalian  reoviruses  (11).  To  determine  if CHT  activity  was  present  in 
newborn  mice,  we  measured  enzyme  activity  of  sonicated  1-  to  2-d-old  mouse 
intestines.  The CHT  activity present  in  1- to 2-d-old mouse intestine was found to be 
41.6  +  7  U/100  g  body wt.  This  value  is  lower  than  the  ~200  U/100  g  body wt 
previously  reported  for  newborn  rats  (28).  To  determine  the  amount  of enzyme 
protein  corresponding to 41.6 U, intestinal  CHT  activity was related  to the specific 
activity of known concentrations of purified enzyme. The activity was equivalent  to 
~4 #g of purified  CHT.  This  value  is  a  minimum  value  because  dietary  proteins, 
natural  substrates  for CHT, were present  in the in vitro reaction mixture. Thus, the 
pancreatic enzyme CHT  is present  in newborn  mice.  To determine  the effect CHT 
has  on  the  infectivity  of reovirus  serotype  1,  strain  Lang  and  serotype  3,  strain 
Dearing, we examined CHT  digestion  in the presence of different concentrations  of 
Na  ÷, K ÷, and Cs  ÷. The concentrations of monovalent cations are known to affect the 
response of reovirus serotype 3, strain Abney (9-13). The cation concentrations were 
selected to represent:  (a)  in vitro conditions that yielded maximal proteolysis (Fig.  1; 
Table  IIA);  (b)  intracellular  Na  and  K  concentrations  (Table  II B);  and  (c)  cation 
concentrations  found  in  the  upper  gastrointestinal  tract  of newborn  suckling  mice 
(Table II C). 
Maximum proteolytic digestion of the Abney strain of reovirus serotype 3 occurs in 
the  presence  of Cs  ÷  (12,  13).  We  have  found  that  serotype  3,  strain  Dearing  also 
undergoes loss of infectivity in the presence of Cs  ÷, whereas serotype  1, strain Lang is 
not  significantly  affected  (Fig.  1,  column  a).  Thus,  the  serotype  1,  strain  Lang  is 
resistant  to digestion by CHT, whereas  the serotype 3, strain  Dearing is sensitive  to 
proteolytic digestion. When proteolytic digestion proceeds in salt concentrations that 
simulate the monovalent cationic content of intracellular  fluids (Table II B) and that 
of the  upper  gastrointestinal  tract  (Table  IIC),  similar  but  less  marked  losses  of 
infectivity of serotype 3, strain Dearing occur. 
Identifying  the M2 dsRNA Segment as the Gene Responsible for the Differences in Response to DONALD  H.  RUBIN  AND  BERNARD  N.  FIELDS 
Outer Copsid  REDUCTION  IN  TITER  (Loglo) 
Ge,~ome Segment  AFTER  CHT  DIGESTION 
Type or 
Recombirmt  M?.  S~  $4  I- 
t  I  I  I 
3  3  3  3 
63  I  3  3 
54  1  1  3 
204  I  3 
B 
140  3  t  ~:~i~i  i  ~.'..'C~!!!~i~  ~ii!~  ~  ~!:~i~i~i~  !  i  ~] 
0  -1  -2  -3  -4 
-~ Logto 
Fro.  1.  Reduction  in titer  (|og~0) after CHT  digestion. Selected  viral  stocks were  incubated  with 
CHT  in the presence of Cs  + as described  in Table I. The parental  origins of the genorne segments 
encoding the three outer capsid polypeptides are listed. 
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Proteolysis.  To  identify  the  gene(s)  responsible  for  the  different  responses  of the 
reovirus serotypes to enzymatic digestion, we used several recombinant clones derived 
from crosses between  reovirus serotypes  1,  strain  Lang and  3,  strain  Dearing and 
which consisted of different combinations of genomic segments  derived from both 
parents  ([23];  and Table I). The isolation of these recombinants and  the methods 
used to determine the genotypes have been previously described (23, 24). 
Clone 65 was studied first because all the dsRNA segments that encode outer capsid 
polypeptides (M2, S I, $4) were derived from serotype I, whereas most of the dsRNA 
segments that encode internal and nonstructural polypeptides were derived from type 
3 (Table I). The pattern of response to CHT digestion under all salt conditions was 
similar to the pattern seen with serotype 1, strain Lang, i.e., there was only a  slight 
decrease in infectivity when digestion was carried out in the presence of CsCl and an 
increase  in  titer  in  conditions  similar  to  gastric  fluids  (Table  II).  These  results 
suggested that one or more components of the outer capsid were playing the primary 
role in sensitivity to CHT digestion. 
Subsequent experiments focused on recombinants that segregated dsRNA segments 
encoding polypeptides of me outer capsid (M2, S 1, $4). The results with a number of 
recombinants excluded both the S 1 and $4 segments and indicated a primary role for 
the  product  of the  M2  dsRNA  segment.  In  the  presence of 0.10  M  Cs  +,  the  salt 
condition that is optimal for the digestion of type 3, strain Dearing, the recombinants 
that  contained  an  M2  dsRNA  segment  from  serotype  1,  strain  Lang  lost  little 
infectivity; whereas the infectivity of recombinants with an M2 dsRNA derived from 
type 3, strain Dearing was reduced markedly (Fig.  1; Table II A). The role of the M2 
gene segment in determining resistance to proteolytic digestion is best illustrated in 
recombinant 63. Recombinant 63 contains an M2 segment derived from serotype 1, 
and S 1 and $4 segments (the other dsRNA segments encoding outer capsid proteins) 
from  type  3;  recombinant  63  behaves  entirely  like  serotype  1  when  exposed  to 858  ROLE OF THE  REOVIRUS M2 GENOME SEGMENT IN VIRULENCE 
TAttLE  II 
Effect of CHT Digestion in the Presence of Various Salts on the Infectivity of Reovirus Serotype 1, 
Strain Lang, Reovirus Serotype 3, Strain Dearing, and Reovirus Recombinants 
Genes encoding outer 
capsid polypeptides  Salt conditions 
Serotype or 
recombinant  A. Maximal  B. Intracellular  C. Upper gas- 
trointestinal tract  M2  S1  $4  (0.10 M CsCI;  (0.145 M KCI; 
0.10 M NaCI)  0.010 M NaCI)  (0.030  M KCI; 
0.010 M NaC1) 
1  1  *  1  1  -0.18  +0.34  +0.33 
3  3  3  3  --3.92  -1.47  -1.35 
65  1  1  1  -0.79  +0.01  +0.29 
54  1  1  3  -0.45  +0.32  +0.43 
63  1  3  3  -0.17  +0.36  +0.39 
204  1  3  I  -0.59  +0.27  +0.36 
402  3  3  1  -4.15  --1.75  -1.17 
502  3  3  3  ND  -  1.30  -  1.40 
602  3  3  1  ND  -  1.80  -0.89 
802  3  1  3  -3.39  -2.09  -  1.04 
94  3:~  3  1  -l.96  -1.15  +0.09 
103  3~:  1  1  -3.04  -  1.06  -0.16 
140  3:[:  1  1  -2.82  -  1.30  +0.09 
Reovirus serotypes  1, strain Lang, type 3, strain Dearing, and recombinant clones were incubated 
with CHT at  37°C for  1 h  in one of three cation conditions..The conditions were selected  to 
simulate Na  + and K ÷ content of selected body fluids: A, maximal conditions of digestion  (Cs+), B, 
intraceUular,  or C, upper gastrointestinal tract. After incubation, the samples  were placed on ice 
and the CHT was inactivated with 1% aprotinin. The samples were titered on L cell monolayers 
as described  in Materials and Methods. The numbers represent  loss (-) or gain (+) in infectivity 
(log~0) of samples treated with CHT compared with untreated controls.  ND, not done. 
* Numbers represent  parental origin of outer capsid genome segments. 
:1:M2 dsRNA segments  that have a nontemperature-sensitive mutation. 
proteolytic  enzymes.  Thus  the  only  outer  capsid  protein  derived  from  serotype  1, 
strain  Lang in this enzyme-resistant  recombinant  is the #IC  polypeptide.  In a  similar 
way,  recombinant  140  has  an  M2  segment  derived  from serotype  3  and  every other 
structural  gene derived  from serotype  1;  infectivity after  proteolysis  is  reduced  in  a 
manner  similar to that  of the serotype 3  parent.  In all other recombinants  examined, 
the  parental  origin of the other two outer capsid  polypeptides  (coded  for by  the S1 
and  $4  genome  segments)  did  not  correlate  with  the  pattern  of reaction  to  CHT 
digestion. Similarly, all the core and nonstructural  polypeptides were excluded. Thus 
the/~IC  polypeptide  is solely responsible  for determining  sensitivity  or resistance  to 
proteolysis in the presence of CsCI. 
With  salt conditions simulating those of an  intracellular  environment,  the recom- 
binants  reacted  to CHT  digestion  in  a  manner  similar to but  less marked  than  that 
found in the presence of CsCI  (Table IIb). Under  these more-physiologic conditions, 
the ~IC  polypeptide  also determines resistance to proteolysis. 
Because  the  overall  goal  of these  studies  was  to  evaluate  viral  entry  through  the 
gastrointestinal  tract,  CHT  digestion  was  performed  under  conditions  that  closely 
simulated  fluid contents  of the  stomach  and  upper  small  intestine.  It  has  not  been 
feasible  to  perform  in  vitro experiments  directly  utilizing  the  intestinal  contents  of DONALD H. RUBIN AND BERNARD N.  FIELDS  859 
newborn mice because of the difficulty in obtaining sufficient amounts of intestinal 
fluid. Gastric contents, which consist largely of milk, are viscous and therefore dilution 
was  required  to  achieve a  liquid  suspension.  Gastric  contents  were  collected and 
pooled from five suckling mice and were analyzed for concentrations of Na  + and K + 
by standard flame photometric techniques (model 343; Instrumentation Laboratory, 
Inc., Lexington, Mass.). The concentrations of these two cations were: Na  + =  0.01  M; 
K + =  0.03 M. Gastric contents were than diluted twofold (total vol: 200 #1) in 0.03 M 
K, 0.01  M  Na, and  2.5 #g  (~107"~ pfu)  of reovirus serotypes  1 and  3  were added. 
There was no change in titer of either reovirus serotypes 1 or 3 after 2 h of incubation 
at  37°C.  When  2.5 #g of reovirus serotypes  1 and  3  were incubated  at  37°C  with 
sonicated whole small intestine (50 p.l) that was obtained from 2-d-old mice, reovirus 
serotype  1 increased in  titer ~0.7  log10, whereas serotype 3  decreased in  titer -1.2 
loga0 during the 2-h incubation period. Thus, incubation of reovirus serotype 3 with 
homogenates of small intestine, but not stomach, decreases the titer ~ 1.2 logs. 
To determine if the pancreatic protease CHT might account for the decreased titer 
of serotype  3  in  intestinal  homogenates,  we  attempted  to  closely  reproduce  the 
physiologic salt conditions of the upper small intestine in vitro. Because of the small 
size  of the  intestine  of newborn  mice,  we  were  unable  to  directly  measure  the 
concentration of cations present at  the sites of entry of pancreatic secretions in the 
duodenum. It is known that the concentration of cations present in the upper small 
intestine  depends  upon  the  secretion of enzymes and  sodium  bicarbonate  by  the 
pancreas, the absorptive capacity of the intestinal epithelium, and the dietary intake 
of solids and fluid (32, 33). The capacity of the pancreas to develop a secretory phase 
is not mature in newborn rodents  (34).  Hence, dietary concentrations of cations, as 
measured in the stomach, assume a greater influence on the concentration of cations 
in the upper small intestine. The concentration of cations present in the stomach, as 
determined above, was used as an approximation of the cation content of the upper 
duodenum. When virus was treated with CHT in the presence of these concentrations 
of cations, the titer of serotype 3, strain Dearing was reduced. We detected a  slight 
increase in titer in serotype 1 (Table II C). Although all recombinants that contained 
an M2 segment derived from serotype 1 were similar to serotype l, certain recombi- 
nants that contained an M2 dsRNA segment derived from serotype 3 more closely 
resembled serotype 1 than serotype 3 (Table III, recombinants 94, 103, and 140). The 
aberrant behavior of these three recombinants was initially unexplained. However, in 
attempting to understand these results, three prior observations were noted: (a) These 
three recombinants  were all  derived from crosses  involving tsD(357)  and  tsG(453) 
(Table I; and [18,  24]); (b) both tsD and tsG mutants had previously been shown to 
synthesize # 1C polypeptides of abnormal mobility on polyacrylamide gel electropho- 
resis  (35)  and,  in  fact,  the  /~IC  polypeptide of tsD(357)  produces  altered  tryptic 
digestion products (36); and (c) in both cases, the aberrant # 1C polypeptide is not the 
site of the ts mutation (tsD ~  LI, tsG -- $4 [23, 24]) but, rather, is the location of a 
silent  nontemperature-sensitive mutation  (35).  For these  reasons,  we  hypothesized 
that the mutation causing the abnormal #1C polypeptide in tsD357 and tsG453 might 
have conferred resistance to CHT digestion. This has been shown to be the case (D. 
H.  Rubin.  Unpublished  data.).  Thus the M2 dsRNA segment  in recombinants 94, 
103, and 140, although derived from serotype 3, was mutated in tsD(357) and tsG(453) 
and  thus behaves differently from the M2 dsRNA segment  derived from the wild- 860  ROLE OF THE REOVIRUS M2 GENOME SEGMENT IN VIRULENCE 
type serotype 3, strain Dearing parent. This fact is noted in Table II by recording the 
serotype 3  M2 segments derived from mutants with altered #1(2 polypeptides with 
double daggers  (:[:). Thus, the altered response of recombinants 94,  103, and  140  to 
(2HT digestion  in  cation  conditions  that  simulate  gastric  content  is  a  result  of a 
previously unrecognized property of the nontemperature-sensitive mutations  in  the 
M2 dsRNA segments derived from tsD(357)  and  tsG(453).  It should also be noted 
that the response to (2HT digestion of these three recombinants in the presence of (2s  + 
or high K ÷, although similar to the wild-type serotype 3 #IC, is less marked. 
The M2 dsRNA Segment Determines the Pattern of Viral Growth in Intestinal  Tissues after 
Gastric Inoculation of Reovirus Serotypes.  To determine whether the difference in sensi- 
tivity of rex)virus serotypes 1 and 3 to proteolytic enzymes plays an important role in 
the entry of viruses through the gastrointestinal tract, we studied inoculation of virus 
into  1-  and  2-d-old BALB/c mice.  Because of the small  size of these  mice, it  was 
difficult to be certain  that  virus was  introduced solely into  the  stomach.  Because 
inoculation of reovirus serotype 3 into the peritoneal cavity often results in a  lethal 
infection  (D.  Rubin.  Unpublished  observations.), we  had  to  insure  that  virus was 
properly administered.  To insure delivery of virus solely to the stomach, virus was 
diluted  with  gelatin  saline  that  contained  a  nonadsorbable  blue  dye.  Virus  was 
inoculated  via  a  polyethylene catheter  into  the  stomach.  We  were  then  able  to 
determine, by examining the nearly transparent abdominal wall for the location of 
the  blue  dye,  if performation of the  intestine,  aspiration  into  the  lungs,  or  other 
mishaps had occurred (Fig. 2). 
When either low (10  a pfu/mouse) or high (107 pfu/mouse) viral inoeula were used, 
titers of virus recovered from intestinal tissues 6-h-8-d after infection were higher with 
serotype 1 than with serotype 3. After inoculation of serotype 1 infection at a dose of 
10  a pfu/mouse, titers of-1  ×  10  ~ pfu/ml serotype 1 virus could be recovered at 48 h. 
No infectious virus could be recovered after inoculation with serotype 3 at this dose. 
After inoculation of virus at doses of 107 pfu/mouse, virus could be recovered from 
intestinal  tissue  for  both  serotypes  1 and  3.  This  dose  corresponded  to  the  virus 
concentration used in the in vitro studies. The higher dose was selected for detailed 
analysis in vivo. 
Because we were mainly concerned with entry of virus through the gastrointestinal 
tract, our detailed studies were done on  days  1-3 after infection. Serotype  1 virus 
significantly increased in titer during the first day and reached a titer of-->10  s pfu/ml 
at 24 h.  Serotype 3 declined to a  titer of ~10  e pfu/ml at  24 h  (Fig.  3a). Thus the 
serotype 1, strain Lang virus, which is resistant to (2HT digestion in vitro, grows more 
efficiently in intestinal tissues. 
To  identify  the  genetic  basis  of the  patterns  of viral  growth,  we  studied  the 
recombinant clones previously analyzed in vitro. (21ones 54, 63, 65, and 204 all contain 
an M2 dsRNA of serotype 1 and resemble serotype 1 in their growth properties (Fig. 
3 b).  In a  similar fashion, recombinants 402,  502, 602,  and  802 all contain  an  M2 
dsRNA of serotype 3 and resemble serotype 3 in their loss of titer (Fig. 3 C). 
Reeombinants containing the altered ((2HT resistant) serotype 3 # 1C polypeptide 
(Table II, recombinants 94, 103, and  140) displayed in vivo an early increase in titer, 
like serotype 1 (Fig. 3 d). However, at a later time, there was more variability in their 
pattern of growth (for example see the titer of clone 94 at day 3). Thus the altered in 
vitro behavior of the #1(2  polypeptide to  proteolytic digestion  corresponds to  the Fro.  2.  External and internal appearance of mice after administration of virus by peroral intu- 
bation. (A) External appearance of mice: left--control mouse showing milk prominently visible in 
stomach;  center--mouse  inoculated  successfully  as indicated  by  darkening of stomach  as  seen 
through abdominal wall; and right--mouse accidentally inoculated into peritoneal cavity showing 
darkening of peritoneal cavity outlining the whitish milk in stomach. Arrow points to whitish milk 
in stomach (left);  stomach darkened by correctly inoculated virus suspension containing blue dye 
(center); and darkening of peritonium by improperly inoculated stock (right). (B) Appearance of 
abdominal viscera 0f mice shown in (A) after abdominal incision. Arrow points to normal peritoneum 
and small intestine (left);  normal stomach and small intestine darkened with blue dye in lumen 
(center); and staining of peritonium because of perforation from improper inoculation (right). X 4. 
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Fro.  3.  Multiplication of reovirus serotype 1, reovirus serotype 3, and selected recombinant clones 
in  intestinal tissue after administration  of virus (~10 T pfu/mouse)  by peroral  intubation.  The 
method of inoculating mice and titering of virus from intestinal tissue is indicated in Materials and 
Methods. Each point represents the mean of three to nine animals. (A) Reovirus serotype 1 (O); 
reovirus serotype 3 (0); (B) recombinants 54 (11), 63 (17), 204 (&), 65 (A); (C) reeombinants 602 
(ill), 502 (Fq), 802 (A), and 402 (A); (D) recombinants 140 (11), 94 (r-I), and 103 (A). 
enhanced  ability  of these  strains  to  grow  in  intestinal  tissue  in  vivo.  This  finding 
strongly suggests that  the resistance  of the #IC polypeptide  to proteolytic digestion 
contributes to the capacity of the virus to grow in intestinal  tissue. 
The  Capacity of Reovirus  to  Grow  in  the  Intestine  Determines  the  Pattern  of Systemic 
Infection.  Serotype  3  reovirus,  when  inoculated  by various  routes  (intracerebral  or 
subcutaneous,  e.g.)  is highly virulent  (37, 38).  Death occurs in virtually all animals, 
even  after  inoculation  of low  doses,  because  virus  infects  neurons  and  produces  a 
necrotizing encephalitis  (20). Infection with serotype  1 reoviruses is relatively benign 
because  the  virus  infects ependymal  cells  and  produces  an  acute ependymitis  (39). 
This  difference  in  pattern  of illness  is  a  function  of the  ol  polypeptide--the  viral 
hemagglutinin--encoded  by the S1 dsRNA segment  (20). To determine whether the 
differences in capacity of reovirus serotypes  1 and 3 to grow in intestinal  tissue affects 
viral  virulence,  we analyzed the effect of administering  serotype  1, strain  Lang and DONALD H.  RUBIN AND BERNARD  N.  FIELDS  863 
serotype 3, strain Dearing by perora[ intubation on their capacity to produce lethal 
central nervous system disease. Because serotype  1 reovirus does not  produce lethal 
infection, even after direct intracerebral inoculation, it was not surprising that very 
few animals died when inoculated perorally (Table III). However, even after inocula- 
tion by peroral intubation of high doses ofserotype 3, strain Dearing, very few animals 
died (Table III) despite the virulence ofserotype 3 when inoculated intracerebrally or 
subcutaneously (20, 37). 
The role of the product of the M2 dsRNA segment in determining the outcome of 
inoculation of reovirus into the stomach was dramatically illustrated by experiments 
with recombinants such as 63 and 204 that contained an M2 segment from serotype 
1 (enzyme resistant) and an S 1 segment from serotype 3  (neurotropic). In contrast to 
either parental serotype, recombinants 63 and 204 were virulent (Table III). Recom- 
binants that contain serotype 3  M2  and S1  dsRNA segments, such  as 402, 502, and 
602, generally behaved in a  fashion similar to the serotype 3 parent and produced a 
nonlethal  infection  (Table  III).  Recombinant  94  contained  an  $1  dsRNA  from 
serotype 3  and the mutant  M2 dsRNA from  ts D357  (23),  It behaved more like the 
serotype 1 parent when digested in vitro in monovalent cations that simulated gastric 
contents (Table II, column C) and when analyzed for growth in intestinal tissue (Fig. 
3 d). Recombinant 94 was significantly more virulent than serotype 3, strain Dearing, 
yet not as virulent as recombinant clones containing a  serotype 3  S 1 dsRNA and a 
serotype 1 M2 dsRNA. Thus the altered serotype 3  M2 dsRNA segment of clone 94 
TABLE III 
Survival of Suckling Mice after Inoculation by Peroral lntubation with Reovirus 
Serotype 1, Strain Lang, Reovirus Serotype 3, Strain Dearing and 
Recombinants 
Serotype or re-  Genotype 
No. mice dead/total  P value*  combinant  M2  S1 
% 
1  1  1  1/33  (3) 
3  3  3  1/42  (2) 
54  1  l  0/1l  (0) 
63  1  3  25/72 (35) 
204  1  3  27/49 (55) 
94  3  3  10/48 (21) 
103  3  I  0/21  O) 
402  3  3  2/24  (8) 
502  3  3  1/23  (4) 
602  3  3  4/33 (l 2) 
.~0.0002 
<0.0001 
<0.02 
>0.65 
>0.70 
>0.20 
Mice were examined for 3 wk after administration of 10  T  pfu of virus/mouse 
by peroral intubation. Most deaths occurred between days 9 and 15. Histo- 
logic examination  of brains collected from sick animals that were infected 
with recombinant clones that contained an S ! segment derived from serotype 
3, revealed neuronal destruction similar to that previously reported (20). 
* The survival oftbe mice inoculated With recombinant clones that contained 
the serotype 3 S1 gene were compared with the survival of mice inoculated 
with serotype  3 as indicated in  Materials and Methods.  P  values <0.05 
indicate significant differences between the recombinant  and serotype 3. 864  ROLE  OF  THE  REOVIRUS  M2  GENOME  SEGMENT  IN  VIRULENCE 
has increased the capacity of the Dearing strain to grow and ultimately produce fatal 
disease. 
The  titers  of  virus  recovered  in  the  brain  after  viral  inoculation  by  peroral 
intubation corresponded to those expected from the patterns of virulence noted above; 
the highest titers were found after inoculation with recombinants that contained M2 
ofserotype 1 and S 1 from serotype 3; whereas lowest titers were found after inoculation 
of viruses that contained an M2 of serotype 3 and an S 1 of serotype 1 (D. n.  Rubin. 
Unpublished data.). 
These  experiments  directly  demonstrate  that  combining  a  CHT-resistant  M2 
genome segment  from serotype  1 (or a  CHT-resistant mutant  M2 genome segment 
derived from a mutant of serotype 3) with the neurovirulent S 1 genome segment from 
serotype 3,  results  in  a  virus  that  is  virulent  after administration  of virus  into  the 
stomach.  These  recombinants  are  considerably  more  virulent  than  either  of  the 
parental serotypes. 
Discussion 
The  results  of this  study  indicate  that  the  M2  dsRNA  genome segment,  which 
encodes the major btlC outer capsid polypeptide, is responsible for the difference in 
virulence when the Dearing strain  is inoculated  perorally as compared to the intra- 
cerebral route.  After inoculation of virus directly into the upper intestinal  tract, the 
Dearing strain behaves as an avirulent strain, whereas inoculation by the intracerebral 
route results in a  highly lethal  (virulent)  infection. The differences in response have 
been  stu~lied  in  vitro and  in  vivo.  With  recombinant  clones  derived  from  crosses 
between reovirus serotype 1, strain Lang and serotype 3, strain Dearing, we have been 
able to show that the M2 dsRNA segment, which encodes the ~IC polypeptide, is the 
segment responsible for differences in response to CHT in vitro. The serotype 1, strain 
Lang  is  resistant  to  inactivation  either by intestinal  homogenates or by the  serine 
protease CHT  in  cation  conditions  that  simulate  the  upper  intestines;  serotype  3, 
strain  Dearing  is highly  susceptible to inactivation  both by intestinal  homogenates 
and by treatment with enzymes in vitro. Recombinants that contain the M2 derived 
from the serotype  1, strain  Lang parent  behaved like serotype 3.  The exceptions to 
this  behavior  involved  recombinants  in  which  the  M2  segment  was  derived  from 
serotype 3 clones  that  contained  mutations  in  the  M2 segment  that  had  conferred 
increased resistance to CHT digestion. 
That in vitro digestion of reovirus by CHT mimics the growth pattern of reovirus 
serotypes and recombinants in the intestine strongly suggests that CHT is playing a 
role in the pattern of viral growth in vivo. 
The  in  vitro responses  to digestion  by CHT  paralleled  the  pattern  of growth  of 
virus in  the small  intestine  as well  as the  ability of the  virus to enter the  systemic 
circulation  and  ultimately  cause  fatal  encephalitis.  After  peroral  inoculation,  the 
serotype 1, strain Lang grew in intestinal tissue, whereas the titers of serotype 3, strain 
Dearing progressively declined.  Furthermore, in the case of the serotype 3 strain that 
is highly neurovirulent after parenteral inoculation, death does not occur when virus 
is introduced into the intestinal tract. Recombinants that contain a protease-resistant 
M2  gene product  derived  from serotype  1 reovirus can  resist  proteolysis of enteric 
fluids and, if they contain a serotype 3 hemagglutinin (S 1 gene product), are virulent 
after inoculation of virus perorally. The M2 genome segment is thus a virulence gene DONALD H. RUBIN AND BERNARD N. FIELDS  865 
because it directly affects the ability of the reoviruses to cause disease after introduction 
into the gastrointestinal tract. 
How could sensitivity to CHT affect the intestinal phase of infection? It seems to 
us that there are two possibilities. First, proteases may affect viruses directly as they 
pass through gastrointestinal fluids. Secondly, they may affect the absolute titer of 
virus after release  from sites of primary multiplication within the  intestinal  tract. 
Clearly, both mechanisms may be taking place. We have shown that direct inactiva- 
tion of virus by intestinal homogenates causes a reduction of viral titers. However, the 
persistence  of serotype  3  reovirus  in  intestinal  tissues  for  3  d,  albeit  in  reduced 
amounts, strongly suggests that  serotype 3  virus  is being synthesized. Because the 
precise site in the intestinal tract of primary viral multiplication has not been defined, 
we  have  not  yet  resolved  this  issue.  It  is  quite  likely, however,  that  by whatever 
mechanism, proteases are participating in  maintaining viral levels below a  critical 
threshold that is required for effective spread to the systemic circulation and ultimately 
to the brain. 
The precise site of proteolysis of virus in vivo, whether in the intestinal lumen or at 
the surface of intestinal cells (27, 31), is also not known. Gastrointestinal proteolytic 
enzymes are produced primarily in the stomach and the pancreas. Pancreatic enzymes 
are secreted  into the small  intestine where  they play a  major role  in  digestion of 
dietary proteins (31, 40). Proteolytic enzymes are found not only in intestinal secretions 
but are also major components of blood serum (complement, clotting factors), major 
products of cells that are important in host defense (macrophages), and are distributed 
in most organs of the body (41, 42). 
These experiments indicate how gastrointestinal disease and nutrition could affect 
viral entry. Diseases with reduced secretion or activity of gastric or pancreatic enzymes 
such as cystic fibrosis, kwashiorkor, chronic pancreatitis, postgastrectomy syndrome, 
could, by reducing the amount of proteolytic enzymes available  (43-45),  increase 
susceptibility of the host to enteric viruses. Furthermore, dietary factors that may alter 
cation concentration or the activity of proteolytic enzymes, (i.e. protease inhibitors), 
could possibly modify the entry of otherwise nonvirulent viruses. 
These results thus define a  second virulence gene for the mammalian reoviruses 
and demonstrate how specific viral components interact with the environment of the 
intestinal tract.  Further exploration of viral  host interactions may have important 
implications for understanding the relationships of diet, gastrointestinal disease, and 
viral pathogenesis. 
Summary 
The mammalian reoviruses (serotype 1, strain Lang and serotype 3, strain Dearing) 
differ in their sensitivity to digestion by chymotrypsin. We have found that the M2 
double-stranded  RNA  (dsRNA)  genome segment  (encoding the #IC  outer capsid 
polypeptide) is responsible for this property. In addition to determining response to 
protease  treatment  in  vitro,  we  have  found  that  the  M2  genome  segment  also 
determines the ability of these two viruses successfully to initiate local and systemic 
infection in newborn mice after peroral inoculation. Thus the M2 dsRNA segment 
defines a new virulence gene of the mammalian reoviruses. 
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